share_log

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife S7 System Medical Professional Training

Accuray Celebrates Opening of Genolier Innovation Hub in Switzerland, Initiation of CyberKnife S7 System Medical Professional Training

精确射线在瑞士Genolier创新中心开幕,启动了CyberKnife S7系统医疗专业培训
PR Newswire ·  09/30 07:35
  • Accuray is the first industry partner to open a facility at the Genolier Innovation Hub, created to provide opportunities for clinician-industry collaborations that can help accelerate improvements in patient care
  • New Accuray CyberComm tool was used to significantly reduce the CyberKnife S7 System's commissioning time and enable product training in Genolier to begin more quickly
  • 精确射线是第一个行业合作伙伴,在Genolier创新中心开设设施,旨在为临床医生和行业合作提供机会,帮助加快改善患者护理。
  • 新的精确射线CyberComm工具已被用于显著缩短CyberKnife S7系统的投运时间,使Genolier中的产品培训得以更快开始。

MADISON, Wis., Sept. 30, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today the initiation of CyberKnife S7 System medical professional training at its education center located within the newly opened Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in Switzerland. As the first industry partner to have a presence at the hub, Accuray now offers product training, and facilitates sharing of best practices and innovative techniques, on both its CyberKnife and Radixact Radiation Treatment Delivery Systems. Accuray began hosting Radixact System educational courses earlier in 2024.

2024年9月30日,威斯康星麦迪逊 / PRNewswire / - 精确射线公司(纳斯达克:ARAY)今天宣布在瑞士新开设的Genolier创新中心教育中心启动CyberKnife S7系统的医疗专业培训。作为第一个在中心设立业务的行业合作伙伴,精确射线现在提供产品培训,并促进其CyberKnife和Radixact放射治疗传递系统的最佳实践和创新技术的分享。精确射线在2024年早些时候开始举办Radixact系统的教育课程。

A three-day series of events marked the grand opening of the state-of-the-art Genolier Innovation Hub, unique in Europe. "We congratulate the Genolier Innovation Hub team on the launch of their new facility and network. They are changing the model for cross-disciplinary collaboration in support of advancing patient care," said Sandeep Chalke, interim CEO & Senior Vice President, Chief Commercial Officer, at Accuray.

一系列为期三天的活动标志着欧洲独特的尖端Genolier创新中心的隆重开幕。精确射线公司临时CEO兼高级副总裁兼首席商务官Sandeep Chalke表示:“我们祝贺Genolier创新中心团队开设新设施和网络。他们正在改变跨学科协作模式,支持推进患者护理的进展。”

Continued Mr. Chalke, "We opened our European education center within the hub to expand access to advanced training to more Accuray CyberKnife and Radixact System users. We are committed to improving the lives of people diagnosed with cancer and this goal is intricately linked to our customers' ability to optimize their use of our systems. The opportunity to easily access training, such as the courses we offer at our center in Genolier, is critical to their success."

Chalke先生继续说:“我们在中心内开设了欧洲教育中心,为更多精确射线CyberKnife和Radixact系统用户提供更先进的培训。我们致力于改善被诊断为癌症患者的生活,这一目标与我们的客户能够优化使用我们系统的能力息息相关。轻松获取培训机会,如在Genolier中心提供的课程,对于他们的成功至关重要。”

The Accuray education center in Genolier was designed from the ground up to provide a comprehensive learning experience. The training curriculum is created to reflect the distinctive needs of the diverse medical professionals involved in the care of patients treated using radiosurgery and radiotherapy. Course attendees have access to expert instructors and hands-on simulation facilities for training and demonstrations of the CyberKnife and Radixact Systems.

Genolier中的精确射线教育中心从根本上设计为提供全面的学习体验。培训课程旨在反映参与放射外科和放射治疗护理的多样医疗专业人员独特的需求。参与课程的学员可以接受专业指导员指导,并使用模拟设施进行CyberKnife和Radixact系统的培训和演示。

The CyberKnife and Radixact Systems have complementary clinical applications with the same goal: to empower customers to deliver the most precise and accurate treatments while still minimizing dose to healthy tissue, helping to reduce the risk of side effects that may impact patients' quality of life. The systems include advanced functionality that make it easier and more efficient to administer extremely precise radiation treatments, even to targets that move, providing the medical care team with options for managing the full spectrum of cancer cases, from routine to complex and initial treatment to retreatment, and neurologic disorders.

精确射线和Radixact系统具有互补的临床应用,目标相同:赋予客户提供最精确和准确的治疗的能力,同时最大限度地减少对健康组织的剂量,有助于减少可能影响患者生活质量的副作用的风险。这些系统包括先进功能,使得更容易和更高效地执行极其精确的放射治疗,甚至对于运动目标,为医疗团队提供管理癌症病例完整范围的选择,从常规到复杂以及初治疗到再治疗,以及神经疾病。

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit or follow us on Facebook, LinkedIn, X, and YouTube.

关于Accuray公司
Accuray致力于扩大辐射治疗的强大潜力,以尽可能地改善生活。我们发明了独特的、市场领先的解决方案,旨在为即使是最复杂的病例提供辐射治疗 - 同时使常见的病例治疗变得更加容易 - 以满足患者需求的全谱。我们致力于在放射治疗、神经放射外科等方面的不断创新,与临床医生和管理人员合作,赋予他们帮助患者更快地回到生活的能力。Accuray总部位于威斯康星州麦迪逊市,并在全球设有设施。欲了解更多信息,请访问或在Facebook、LinkedIn、X和YouTube上关注我们。

Safe Harbor Statement
Statements made in this press release that are not statements of historical fact are forward-looking statements and are subject to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements in this press release relate, but are not limited to, expectations related to expectations regarding the Genolier Innovation Hub and the Company's education center located within Genolier; expectations regarding the Company's training curriculum; and expectations regarding the Company's products. These risks and uncertainties include, but are not limited to, the effect of the current global economic environment, including in connection to the COVID-19 pandemic, on the operations of the company and those of its customers and suppliers; the company's ability to achieve widespread market acceptance of its products; the company's ability to develop new products or improve existing products to meet customers' needs; the company's ability to anticipate or keep pace with changes in the marketplace and the direction of technological innovation and customer demands; reliance on third party collaborators, partnerships, strategic alliances and joint ventures; and such other risks identified under the heading "Risk Factors" in the company's Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on September 19, 2024, and as updated periodically with the company's other filings with the SEC.

Safe Harbor声明
本新闻稿中提到的观点,若非历史事实陈述,则属于前瞻性声明,并受1995年《关于私人证券诉讼改革法》“安全港”条款的约束。本新闻稿中的前瞻性声明涉及但不限于与Genolier Innovation Hub和位于Genolier内的公司教育中心相关的期望;与公司的培训课程相关的期望;以及与公司产品相关的期望。这些风险和不确定性包括但不限于当前全球经济环境的影响,包括与COVID-19大流行有关,对公司及其客户和供应商的运营的影响;公司能否广泛获得市场对其产品的接受;公司能否研发新产品或改进现有产品以满足客户需求;公司是否能够预测或跟上市场变化、技术创新的方向和客户需求;依赖第三方合作者、伙伴关系、战略联盟和合资企业;以及在公司的《10-k表》年度报告的“风险因素”标题下确认的其他风险,该报告于2024年9月19日提交给证券交易委员会(“SEC”),并随着公司其他提交给SEC的文件进行定期更新。

Forward-looking statements speak only as of the date the statements are made and are based on information available to the company at the time those statements are made and/or management's good faith belief as of that time with respect to future events. The company assumes no obligation to update forward-looking statements to reflect actual performance or results, changes in assumptions or changes in other factors affecting forward-looking information, except to the extent required by applicable securities laws. Accordingly, investors should not put undue reliance on any forward-looking statements.

前瞻性陈述仅适用于发表陈述的日期,并且是基于公司在那些声明发表时可用的信息和/或管理层对未来事件的信心以及当时的良好信仰。公司假定没有义务更新前瞻性陈述以反映实际表现或结果,也没有义务更新前瞻性信息的假设或影响前瞻性信息的其他因素,除非适用的证券法律要求。因此,投资者不应过度依赖任何前瞻性陈述。

Media Contact
Beth Kaplan
Public Relations Director, Accuray
+1 (408) 789-4426
[email protected]

媒体联系人
Beth Kaplan
公共关系主管,精确射线
+1(408)789-4426
[email protected]

SOURCE Accuray Incorporated

来源:精确射线公司

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

想要您公司的新闻在PRNEWSWIRE.COM上特色呈现吗?

440k+
440k+

Newsrooms &
新闻发布室&

Influencers
影响力
9k+
9k+

Digital Media
数字媒体

Outlets
卖场
270k+
270k+

Journalists
新闻记者

Opted In
已选择加入
GET STARTED
开始使用
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发